Ashley Communications is proud to be the medical education company associated with Vesicare from Astellas, which has recently been classified as a Global Blockbuster and is the No.1 prescribed drug for overactive bladder in Europe. Ashley Communications has been responsible for Vesicare since 2003, taking it through its critical pre-launch, launch and post-launch phases and continue to support Astellas at both a Global and European level.